← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 24, 2020Last known activity
May 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT06324877OfficialN/AMay 1, 2024
- NCT04513002Overall official - principal investigatorPhase 2Mar 31, 2021
- NCT04496245CollaboratorPhase 3Aug 24, 2020
Details
- Last known activity
- May 1, 2024